SCHEMBL7650293

SCHEMBL7650293

C=Cc1ccc(S(=O)(=O)NC(=O)c2ccc3nc(C)n(Cc4ccc(Cl)cc4Cl)c3c2)cc1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.65
FLT1 P17948 10/20 0.43
FLT4 P35916 10/20 0.43
KDR P35968 10/20 0.43
HDAC3 O15379 2/20 0.42
HDAC4 P56524 2/20 0.42
HDAC1 Q13547 2/20 0.42
HDAC7 Q8WUI4 2/20 0.42
HDAC2 Q92769 2/20 0.42
HDAC10 Q969S8 2/20 0.42
HDAC11 Q96DB2 2/20 0.42
HDAC8 Q9BY41 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
HDAC9 Q9UKV0 2/20 0.42
HDAC5 Q9UQL6 2/20 0.42
LMNA P02545 1/20 0.40
ALDH1A1 P00352 1/20 0.39
PTGER4 P35408 1/20 0.39
PTGER3 P43115 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7649107 0.92 PPARG (0.55) PPARGFLT1FLT4KDRHDAC3
SCHEMBL6134973 0.91 PPARG (0.70) PPARGFLT1FLT4KDRHDAC3
SCHEMBL7652972 0.90 PPARG (0.53) PPARGHDAC3HDAC4HDAC1HDAC7
SCHEMBL7652979 0.90 PPARG (0.53) PPARGHDAC3HDAC4HDAC1HDAC7
SCHEMBL7648916 0.90 PPARG (0.53) PPARGFLT1FLT4KDRHDAC3
SCHEMBL7649091 0.90 PPARG (0.53) PPARGFLT1FLT4KDRHDAC3
SCHEMBL1160394 0.89 PPARG (0.70) PPARGFLT1FLT4KDRHDAC3
Hydrochloric Acid SCHEMBL6171221 0.88 PPARG (0.69) PPARGFLT1FLT4KDRHDAC3
SCHEMBL6134713 0.88 PPARG (0.51) PPARGHDAC3HDAC4HDAC1HDAC7
SCHEMBL7653691 0.87 PPARG (0.65) PPARGFLT1FLT4KDRHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420409-B1 GLUCOSE TOLERANCE, DIABETES,INSULIN RESISTANCE, POLYCYSTIC OVARY SYNDROME, HYPERLIPIDEMIA, ATHEROSCLEROSIS, CARDIOVASCULAR DISORDERS, HYPERGLYCEMIA, HYPERTENSION, STENOCARDIA, PULMONARY HYPERTENSION, CONGESTIVE HEART FAILURE, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-07-16 US claimed
EP-1020452-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 EP claimed
US-6420409-B1 GLUCOSE TOLERANCE, DIABETES,INSULIN RESISTANCE, POLYCYSTIC OVARY SYNDROME, HYPERLIPIDEMIA, ATHEROSCLEROSIS, CARDIOVASCULAR DISORDERS, HYPERGLYCEMIA, HYPERTENSION, STENOCARDIA, PULMONARY HYPERTENSION, CONGESTIVE HEART FAILURE, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-07-16 US disclosed
EP-1020452-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 EP disclosed